Publicaciones en colaboración con investigadores/as de University of Parma (64)

2023

  1. Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry

    International Journal of Cardiology, Vol. 392

  2. Effects of midazolam vs morphine in patients with acute pulmonary edema with left ventricular systolic dysfunction: a secondary analysis of data from the MIMO trial

    Emergencias, Vol. 35, Núm. 1, pp. 25-30

  3. Immunosuppression of HLA identical living-donor kidney transplant recipients: A systematic review

    Transplantation Reviews, Vol. 37, Núm. 4

  4. Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements – DEFINE-FLOW core laboratory sub-study

    International Journal of Cardiology, Vol. 377, pp. 9-16

  5. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

    Allergy: European Journal of Allergy and Clinical Immunology

  6. Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN

    Clinical Nutrition, Vol. 42, Núm. 4, pp. 443-457

  7. Prognostic Implications of Individual and Combinations of Resting and Hyperemic Coronary Pressure and Flow Parameters

    JACC: Asia, Vol. 3, Núm. 6, pp. 865-877

  8. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

2022

  1. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction

    Journal of the American Heart Association, Vol. 11, Núm. 9

  2. Combined Assessment of FFR and CFR for Decision Making in Coronary Revascularization: From the Multicenter International ILIAS Registry

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 10, pp. 1047-1056

  3. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom

    PharmacoEconomics, Vol. 40, Núm. 3, pp. 323-339

  4. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180

    Computer methods and programs in biomedicine

  5. Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 10, pp. 1033-1043

  6. Ethical and medical dilemmas in paid living kidney donor transplantation

    Transplantation Reviews, Vol. 36, Núm. 4

  7. Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials

    JTO Clinical and Research Reports, Vol. 3, Núm. 9

  8. Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

    Transplant International, Vol. 35

  9. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Viruses, Vol. 14, Núm. 2